To minimize this experimental variation, we have used telomerase reverse transcriptase (TERT)-immortalized skin KCs to reduce genetic background and to assist in assay transferability, an important consideration if the technology is to be adopted by other laboratories. This evidence concerns the gene TERT and dry eye syndrome.